PharmAware Blog

Senator Charles Grasslet and the US senate committe on finance has called for tougher regulation on ghostwriting in medical journals. The report says that as journals influence prescribing, undisclosed funding by companies can lead to journals inadvertantly promoting sales of a company’s product. He goes on to state, that once strong policy is in place, the difficulty will be with compliance.

BMJ 2010, 340, c3504

There are two interesting letters in this week’s BMJ. The first is from Margaret Chan, director general of the WHO and the second from from Pim Kon, medical director of GSK. Both letters address the possible conflicts of interest in the WHO when making decisions on treatment for H1N1 pandemic flu.

BMJ 2010; 340, c3463